Zambon acquires Breath Therapeutics to advance inhalation therapy for BOS

Zambon, an Italian multinational company, extends its presence in severe respiratory diseases through the acquisition of Breath Therapeutics (Credit: Pixabay)



Related Article
Recommended Whitepaper

View More